PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system... Show more
The Aroon Indicator for PTCHF entered a downward trend on August 22, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator formed such a pattern. In of the 204 cases the stock moved lower. This puts the odds of a downward move at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where PTCHF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PTCHF as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PTCHF turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
PTCHF moved below its 50-day moving average on September 02, 2025 date and that indicates a change from an upward trend to a downward trend.
The RSI Indicator entered the oversold zone -- be on the watch for PTCHF's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The 10-day moving average for PTCHF crossed bullishly above the 50-day moving average on August 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
PTCHF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.996) is normal, around the industry mean (19.852). P/E Ratio (9.118) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (60.606) is also within normal values, averaging (322.082).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTCHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTCHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TSEMX | 16.20 | 0.07 | +0.43% |
Touchstone Sands Cptl Emerg Mkts Gr Y | |||
GTTMX | 20.26 | 0.04 | +0.20% |
Glenmede Total Market Plus Eq Ptf | |||
MXETX | 13.14 | N/A | N/A |
Empower Core Strategies US Eq Inv | |||
GVIYX | 12.55 | N/A | N/A |
GuideStone Funds Value Equity Idx Instl | |||
NRLCX | 49.93 | -0.11 | -0.22% |
Neuberger Berman Large Cap Value R6 |
A.I.dvisor tells us that PTCHF and PHGE have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and PHGE's prices will move in lockstep.
Ticker / NAME | Correlation To PTCHF | 1D Price Change % | ||
---|---|---|---|---|
PTCHF | 100% | -14.84% | ||
PHGE - PTCHF | 22% Poorly correlated | +3.58% | ||
BCTX - PTCHF | 22% Poorly correlated | +9.01% | ||
ACET - PTCHF | 20% Poorly correlated | +2.00% | ||
SBMFF - PTCHF | 18% Poorly correlated | N/A | ||
RVXCF - PTCHF | 10% Poorly correlated | -3.77% | ||
More |